1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Li Z, Ying X, Shan F and Ji J: The
association of garlic with Helicobacter pylori infection and
gastric cancer risk: A systematic review and meta-analysis.
Helicobacter. 23:e125322018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Mao QQ, Xu XY, Shang A, Gan RY, Wu DT,
Atanasov AG and Li HB: Phytochemicals for the prevention and
treatment of gastric cancer: Effects and Mechanisms. Int J Mol Sci.
21:212020. View Article : Google Scholar
|
4
|
Xiao S and Zhou L: Gastric cancer:
Metabolic and metabolomics perspectives (Review). Int J Oncol.
51:5–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wang Y and Morrow JS: Identification and
characterization of human SLP-2, a novel homologue of stomatin
(band 7.2b) present in erythrocytes and other tissues. J Biol Chem.
275:8062–8071. 2000. View Article : Google Scholar : PubMed/NCBI
|
6
|
Deng H, Deng Y, Liu F, Chen J, Li Z, Zhao
K, Guan X and Liang W: Stomatin-like protein 2 is overexpressed in
cervical cancer and involved in tumor cell apoptosis. Oncol Lett.
14:6355–6364. 2017.PubMed/NCBI
|
7
|
Liu D, Zhang L, Shen Z, Tan F, Hu Y, Yu J
and Li G: Increased levels of SLP-2 correlate with poor prognosis
in gastric cancer. Gastric Cancer. 16:498–504. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Yang X, Hu Y, Shi H, Zhang C, Wang Z, Liu
X, Chen H, Zhang L and Cui D: The diagnostic value of TROP-2, SLP-2
and CD56 expression in papillary thyroid carcinoma. Eur Arch
Otorhinolaryngol. 275:2127–2134. 2018. View Article : Google Scholar : PubMed/NCBI
|
9
|
Liu Q, Li A, Wang L, He W, Zhao L, Wu C,
Lu S, Ye X, Zhao H, Shen X, et al: Stomatin-like protein 2 promotes
tumor cell survival by activating the JAK2-STAT3-PIM1 pathway,
suggesting a novel therapy in CRC. Mol Ther Oncolytics. 17:169–179.
2020. View Article : Google Scholar : PubMed/NCBI
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Burgermeister E, Xing X, Röcken C, Juhasz
M, Chen J, Hiber M, Mair K, Shatz M, Liscovitch M, Schmid RM, et
al: Differential expression and function of caveolin-1 in human
gastric cancer progression. Cancer Res. 67:8519–8526. 2007.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang Y, Cao W, Yu Z and Liu Z:
Downregulation of a mitochondria associated protein SLP-2 inhibits
tumor cell motility, proliferation and enhances cell sensitivity to
chemotherapeutic reagents. Cancer Biol Ther. 8:1651–1658. 2009.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang J, Song X, Li C and Tian Y:
Expression and clinical significance of SLP-2 in ovarian tumors.
Oncol Lett. 17:4626–4632. 2019.PubMed/NCBI
|
14
|
Zhou C, Li Y, Wang G, Niu W, Zhang J, Wang
G, Zhao Q and Fan L: Enhanced SLP-2 promotes invasion and
metastasis by regulating Wnt/β-catenin signal pathway in colorectal
cancer and predicts poor prognosis. Pathol Res Pract. 215:57–67.
2019. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liu JZ, Hu YL, Feng Y, Guo YB, Liu YF,
Yang JL, Mao QS and Xue WJ: Rafoxanide promotes apoptosis and
autophagy of gastric cancer cells by suppressing PI3K/Akt/mTOR
pathway. Exp Cell Res. 385:1116912019. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wang G, Zhang T, Sun W, Wang H, Yin F,
Wang Z, Zuo D, Sun M, Zhou Z, Lin B, et al: Arsenic sulfide induces
apoptosis and autophagy through the activation of ROS/JNK and
suppression of Akt/mTOR signaling pathways in osteosarcoma. Free
Radic Biol Med. 106:24–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Nowak KL and Edelstein CL: Apoptosis and
autophagy in polycystic kidney disease (PKD). Cell Signal.
68:1095182020. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kasprowska-Liśkiewicz D: The cell on the
edge of life and death: Crosstalk between autophagy and apoptosis.
Postepy Hig Med Dosw. 71:825–841. 2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
D'Arcy MS: Cell death: A review of the
major forms of apoptosis, necrosis and autophagy. Cell Biol Int.
43:582–592. 2019. View Article : Google Scholar : PubMed/NCBI
|
20
|
Edlich F: BCL-2 proteins and apoptosis:
Recent insights and unknowns. Biochem Biophys Res Commun.
500:26–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tang Q, Bu W, Wang D, Xin Y, Xu X and Sun
H: Advance research on interaction between autophagy and apoptosis
and its influence in development of tumors. J Jilin Univ.
41:1303–1306. 2015.
|
22
|
Cao Y, Luo Y, Zou J, Ouyang J, Cai Z, Zeng
X, Ling H and Zeng T: Autophagy and its role in gastric cancer.
Clin Chim Acta. 489:10–20. 2019. View Article : Google Scholar : PubMed/NCBI
|
23
|
Qian HR and Yang Y: Functional role of
autophagy in gastric cancer. Oncotarget. 7:17641–17651. 2016.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Song J, Zhou Y, Gong Y, Liu H and Tang L:
Rottlerin promotes autophagy and apoptosis in gastric cancer cell
lines. Mol Med Rep. 18:2905–2913. 2018.PubMed/NCBI
|
25
|
Chen X, Wang P, Xie M, Zhao H and Wu H:
Study on mechanism of down-regulation of SLP-2 gene expression on
proliferation and apoptosis of glioma cells. Chin J Immunol.
34:55–59. 2018.(In Chinese).
|
26
|
Yu Z, Chen Y, Liang C and Eriocalyxin B:
Eriocalyxin B Induces apoptosis and autophagy involving
Akt/mammalian target of rapamycin (mTOR) pathway in prostate cancer
cells. Med Sci Monit. 25:8534–8543. 2019. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li Y, Wang C, Liu Y, You J and Su G:
Autophagy, lysosome dysfunction and mTOR inhibition in MNU-induced
photoreceptor cell damage. Tissue Cell. 61:98–108. 2019. View Article : Google Scholar : PubMed/NCBI
|
28
|
Li R, Tan S, Yu M, Jundt MC, Zhang S and
Wu M: Annexin A2 regulates autophagy in Pseudomonas
aeruginosa infection through the Akt1-mTOR-ULK1/2 signaling
pathway. J Immunol. 195:3901–3911. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Karimi-Busheri F, Marcoux Y, Tredget EE,
Li L, Zheng J, Ghoreishi M, Weinfeld M and Ghahary A: Expression of
a releasable form of annexin II by human keratinocytes. J Cell
Biochem. 86:737–747. 2002. View Article : Google Scholar : PubMed/NCBI
|
30
|
Shi H, Xiao L, Duan W, He H, Ma L, Da M,
Duan Y, Wang Q, Wu H, Song X, et al: ANXA2 enhances the progression
of hepatocellular carcinoma via remodeling the cell motility
associated structures. Micron. 85:26–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
31
|
He H, Xiao L, Cheng S, Yang Q, Li J, Hou
Y, Song F, Su X, Jin H, Liu Z, et al: Annexin A2 enhances the
progression of colorectal cancer and hepatocarcinoma via
cytoskeleton structural rearrangements. Microsc Microanal.
25:950–960. 2019. View Article : Google Scholar : PubMed/NCBI
|
32
|
Chen CY, Lin YS, Chen CH and Chen YJ:
Annexin A2-mediated cancer progression and therapeutic resistance
in nasopharyngeal carcinoma. J Biomed Sci. 25:302018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Sharma MC: Annexin A2 (ANX A2): An
emerging biomarker and potential therapeutic target for aggressive
cancers. Int J Cancer. 144:2074–2081. 2019. View Article : Google Scholar : PubMed/NCBI
|
34
|
Wang T, Wang Z, Niu R and Wang L: Crucial
role of Anxa2 in cancer progression: Highlights on its novel
regulatory mechanism. Cancer Biol Med. 16:671–687. 2019.PubMed/NCBI
|
35
|
Cardoso CM, de Jesus SF, de Souza MG,
Queiroz LD, Santos EM, Dos Santos EP, Oliveira LP, Santos CK, Sousa
Santos SH, et al: High levels of ANXA2 are characteristic of
malignant salivary gland tumors. J Oral Pathol Med. 48:929–934.
2019. View Article : Google Scholar : PubMed/NCBI
|
36
|
Yang CT, Li JM, Li LF, Ko YS and Chen JT:
Stomatin-like protein 2 regulates survivin expression in non-small
cell lung cancer cells through β-catenin signaling pathway. Cell
Death Dis. 9:4252018. View Article : Google Scholar : PubMed/NCBI
|